Viewing Study NCT00035906



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00035906
Status: COMPLETED
Last Update Posted: 2011-05-30
First Post: 2002-05-06

Brief Title: Research Study in Patients With Persistent Macular Edema
Sponsor: Allergan
Organization: Allergan

Study Overview

Official Title: Research Study in Patients With Persistent Macular Edema Due to Diabetic Retinopathy Retinal Vein Occlusion Uveitis or Irvine-Gass Syndrome
Status: COMPLETED
Status Verified Date: 2011-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication to treat macular edema that persists despite current treatment methods Participants will be evaluated for improvement in vision and side effects

Macular edema is a condition that affects the back of the eye retina It frequently occurs in people who have a history of diabetes and is also associated with high blood pressure uveitis and previous eye surgery The main symptom of macular edema is decreased vision generally a blurring of central vision

There are no direct costs to participants for assessments and treatment as defined in the study protocol All candidates must be available for required scheduled visits during the trials 6-month follow-up period Although the disease called age-related macular degeneration AMD affects the same region of the eye as macular edema they are not the same condition and AMD is not studied in this research trial
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None